Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04589793
Other study ID # TYH2020338
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2021
Est. completion date September 2025

Study information

Verified date August 2021
Source Helsinki University Central Hospital
Contact Maritta Poyhonen-Alho, PhD
Phone +358 50 428 4690
Email maritta.poyhonen-alho@hus.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In Finland, every third woman is overweight (BMI>25) and 11,5% obese (BMI>30). Cohort and national studies reveal that 46% of fertile-aged men have BMI≥25 and 20% BMI≥30. Overweight has negative impact on both female and male fertility and weakens markedly the results of infertility treatments. In this study, 780 infertile couples will be randomized to control group (conventional infertility treatment) and lifestyle intervention arm undergoing 4 sessions of video-mediated motivational interview, anthropometric measurements, laboratory tests and epigenetic samples. Economic evaluation of the intervention will also be performed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1560
Est. completion date September 2025
Est. primary completion date September 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - infertility - BMI 27-34.9 kg/m2 Exclusion Criteria: - no mobile device available - evident sperm defect or ovarian tube block - hinder for fluent treatment schedule due to the subjec´s obstacle (inadequate language skills, major time table problems)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Life Style
Life Style intervention including physical activity, diet, sleep and stress

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Helsinki University Central Hospital University of Eastern Finland, University of Helsinki

Outcome

Type Measure Description Time frame Safety issue
Primary Behavior change score from 1 to 4: (smoking + daily vegetable, fruit and berry use >500g + BMI 19-27 + 150 min of moderate exercise/week) No=0, Yes=1 measured at the beginning, at 3 and 6 months 6 months
Primary Live birth rate Number of live children born 3 years
Primary Weight change weight in kg measured without shoes and with light clothing at the beginning, at 3 and 6 months 6 months
Secondary Infertility treatments, number Number of infertility treatments needed for a live birth 3 years
Secondary Infertility treatments, mode Mode of infertility treatments needed for a live birth (including ovulation induction, insemination, IVF, ICSI) 3 years
Secondary Miscarriage rate Number of miscarriages 3 years
Secondary Height Measured without shoes (cm) 0 months
Secondary Weight Measured without shoes and with light clothing (kg) 0 months
Secondary Weight Measured without shoes and with light clothing (kg) 3 months
Secondary Weight Measured without shoes and with light clothing (kg) 6 months
Secondary Body mass index Weight in kilograms divided by the square of height in meters 0 months
Secondary Body mass index Weight in kilograms divided by the square of height in meters 3 months
Secondary Body mass index Weight in kilograms divided by the square of height in meters 6 months
Secondary Body composition Bioimpedance method 0 months
Secondary Body composition Bioimpedance method 3 months
Secondary Body composition Bioimpedance method 6 months
Secondary Waist circumference measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm) 0 months
Secondary Waist circumference measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm) 3 months
Secondary Waist circumference measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm) 6 months
Secondary Self-reported physical activity Minutes per week, International Physical Activity Questionnaire - Short Form 0 months
Secondary Self-reported physical activity Minutes per week, International Physical Activity Questionnaire - Short Form 6 months
Secondary Physical activity Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer 0 months
Secondary Physical activity Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer 3 months
Secondary Physical activity Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer 6 months
Secondary Maximal oxygen uptake Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990 0 months
Secondary Maximal oxygen uptake Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990 3 months
Secondary Maximal oxygen uptake Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990 6 months
Secondary Dietary content FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a) 0 months
Secondary Dietary content FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a) 6 months
Secondary Dietary patterns FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a) 0 months
Secondary Dietary patterns FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a) 6 months
Secondary Folate Plasma folate concentration 0 months
Secondary Folate Plasma folate concentration 6 months
Secondary Vitamin-D Plasma vitamin-D concentration 0 months
Secondary Vitamin-D Plasma vitamin-D concentration 6 months
Secondary Zinc Plasma zinc concentration 0 months
Secondary Zinc Plasma zinc concentration 6 months
Secondary Carbohydrates Amount of daily carbohydrates in diet , FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Carbohydrates Amount of daily carbohydrates in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Protein Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Protein Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Alcohol Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Alcohol Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary n-3 fatty acids Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary n-3 fatty acids Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary n-6 fatty acids Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary n-6 fatty acids Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Saturated fatty acids Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Saturated fatty acids Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Monounsaturated fatty acids Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Monounsaturated fatty acids Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Polyunsaturated fatty acids Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 0 months
Secondary Polyunsaturated fatty acids Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a 6 months
Secondary Sleep Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ) 0 months
Secondary Sleep Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ) 6 months
Secondary Sleep, measured Quality, sleep disruptions, total sleep duration registered by Oura ring application 0 months
Secondary Sleep, measured Quality, sleep disruptions, total sleep duration registered by Oura ring application 3 months
Secondary Sleep, measured Quality, sleep disruptions, total sleep duration registered by Oura ring application 6 months
Secondary Stress recovery Night-time heart rate variability regisered by Oura ring application 0 months
Secondary Stress recovery Night-time heart rate variability registered by Oura ring application 3 months
Secondary Stress recovery Night-time heart rate variability registered by Oura ring application 6 months
Secondary Anxiety and depression Hospital Anxiety and Depression Scale (HADS) 0 months
Secondary Anxiety and depression Hospital Anxiety and Depression Scale (HADS) 3 months
Secondary Anxiety and depression Hospital Anxiety and Depression Scale (HADS) 6 months
Secondary Fertility quality of life FertiQoL International Questionnaire 0 months
Secondary Fertility quality of life FertiQoL International Questionnaire 6 months
Secondary Depression Edinburgh Postnatal Depression Scale (EPDS) Questionnaire 0 months
Secondary Depression Edinburgh Postnatal Depression Scale (EPDS) Questionnaire 6 months
Secondary Self-determined motivation for physical activity Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. & Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation. 0 months
Secondary Self-determined motivation for physical activity Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. & Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation 6 months
Secondary Intention and action planning for physical activity; Intention to increase physical activity Three (adapted) items from the Health Action Process Approach Questionnaire, (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29) 0 months
Secondary Intention and action planning for physical activity; Intention to increase physical activity Three (adapted) items from the Health Action Process Approach Questionnaire (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29) 6 months
Secondary Self-efficacy for physical activity 18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337) 0 months
Secondary Self-efficacy for physical activity 18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337) 6 months
Secondary Pregnancy complications Number of pregnancy complications (gestational diabetes, pre-eclampsia, hypertension, fetal growth disorders, preterm birth) 3 years
Secondary Delivery complications Number of delivery complications (cesarean section, assisted vaginal delivery, hemorrhage) 3 years
Secondary Neonatal outcome Birth weight, cord pH, Apgar score 3 years
Secondary Body composition of the newborn Bioimpedance method At birth
Secondary Growth of the child From the records of the national child care centers and schools Up to 16 years of age
Secondary Sperm epigenetic profile Determination of heritable phenotype 0 months
Secondary Sperm epigenetic profile Determination of heritable phenotype 6 months
Secondary Transcriptome RNA-sequencing 0 months
Secondary Transcriptome RNA-sequencing 6 months
Secondary Sperm oxidative stress the Male infertility Oxidative System test (MiOXSYS) 0 months
Secondary Sperm oxidative stress the Male infertility Oxidative System test (MiOXSYS) 6 months
Secondary A cost-utility of the intervention analysis based on WHOQOL-BREF Questionnaire and FertiQoL, relating the quality-adjusted life years (QALYS) to the costs of the intervention 3 years
Secondary QALY baseline WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire 0 months
Secondary QALY end point WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire 6 months
Secondary Cost-effectiveness ICER 3 years
Secondary Static postural balance Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany) 0 months
Secondary Static postural balance Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany) 1st trimester of pregnancy
Secondary Static postural balance Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany) 2nd trimester of pregnancy
Secondary Static postural balance Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany) 3rd trimester of pregnancy
Secondary Static postural balance Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany) 3 months postpartum
Secondary Perception of stress Perceived Stress Scale by Sheldon Cohen 0 months
Secondary Perception of stress Perceived Stress Scale by Sheldon Cohen 3 months
Secondary Perception of stress Perceived Stress Scale by Sheldon Cohen 6 months
Secondary Personality dimensions The Big Five Personality Test 0 months
Secondary Personality dimensions The Big Five Personality Test 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05634850 - Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
Completed NCT03803228 - Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders Phase 3
Active, not recruiting NCT06053827 - Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Recruiting NCT03480412 - Second Step Protocol in Poor Ovarian Responder (POR)
Not yet recruiting NCT04606082 - Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI N/A
Not yet recruiting NCT04604054 - The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF N/A
Completed NCT06441409 - Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease N/A
Completed NCT03846544 - Double Pick up in Poor Prognosis Women Phase 4
Completed NCT04141436 - Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF) N/A
Recruiting NCT05271981 - Fertility After Uterine Artery Embolization
Completed NCT03161873 - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed NCT03007043 - Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
Completed NCT04133402 - Fertility After Intrauterine Tamponing Balloon: Where Are we
Active, not recruiting NCT06128395 - ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Recruiting NCT05807256 - Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Completed NCT03908697 - Quantum Natural Family Planning Pilot N/A
Completed NCT04908774 - Effects of a Fasting Mimicking Diet on Sperm Quality N/A
Recruiting NCT05205733 - Expanding Fertility Care to Poor and Low Resourced Settings Study N/A
Active, not recruiting NCT03085212 - Strategies for Pregnancy Achievement N/A
Completed NCT01388907 - Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery Phase 4